[Usefulness of vasodilator agents Cavinton and Halidor in circulatory insufficiency of the lower limbs].
D000328:Adult; D000368:Aged; D001162:Arteriosclerosis Obliterans / Q000188:drug therapy*; D001537:Bencyclane / Q000627:therapeutic use*; D003508:Cycloheptanes / Q000627:therapeutic use*; D003925:Diabetic Angiopathies / Q000188:drug therapy*; D005260:Female; D006801:Humans; D007866:Leg / Q000098:blood supply*; D008297:Male; D008833:Microcirculation / Q000187:drug effects; D008875:Middle Aged; D012039:Regional Blood Flow / Q000187:drug effects; D014665:Vasodilator Agents / Q000627:therapeutic use*; D014748:Vinca Alkaloids / Q000627:therapeutic use*
D003508:Cycloheptanes; D014665:Vasodilator Agents; D014748:Vinca Alkaloids; C013983:vinpocetine; D001537:Bencyclane
Uzyteczność Cavintonu i Halidoru jako leków rozszerzajacych naczynia w niedostatecznym ukrwieniu kończyn dolnych.